Controversies in heart failure: Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?

Cardiology Clinics

Volumn 19, Issue 4, 2001, Pages 597-603

  Hall, Donald ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FIBRINOGEN RECEPTOR ANTAGONIST; PROSTAGLANDIN;

ANTICOAGULANT THERAPY; DRUG ANTAGONISM; HEART EJECTION FRACTION; HEART FAILURE; HEMODYNAMICS; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; REVIEW; RISK BENEFIT ANALYSIS; THROMBOCYTE AGGREGATION;

EID: 0034755239     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70246-0     Document Type: Article

References (59)

1. Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects
2. Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs
3. Analysis of the effect of indomethacin on the response to furosemide in man
4. Interaction of vasopressin and prostaglandins in the toad urinary bladder
5. Interaction of nonsteroidal anti-inflammatory drugs with antihypertensive and diuretic agents. Control of vascular reactivity by endogenous prostanoids
6. Characterization of furosemide-induced activation of the renal prostaglandin system
7. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
8. Aspirin in coronary heart disease
9. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure
10. The effect of indomethacin on kidney function and plasma renin activity in man
11. Renal prostaglandins and water balance: Studies in normal volunteer subjects and in patients with central diabetes insipidus
12. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease
13. Aspirin and secondary mortality after myocardial infarction
14. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure
15. Prostaglandins in severe congestive heart failure: Relation to activation of the renin-angiotensin system and hyponatremia
16. The role of prostaglandins in the pathophysiology of and therapy for congestive heart failure
17. Interaction of diuretics and non-steroid anti-inflammatory drugs in man
18. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with anti-platelet therapy: Results of a Veterans Administration Cooperative Study
19. Evidence for a dual action of converting enzyme inhibitors on blood pressure in man
20. The aspirin-angiotensin converting enzyme inhibitor tradeoff: To halve and halve not
21. Adverse effect of aspirin on water metabolism in severe heart failure treated with enalapril
22. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
23. Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water
24. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: Modulation by sodium balance
25. Aspirin-induced depression of renal function
26. Influence of nonsteroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension
27. Interaction of conventional and antikaliuretic diuretics with the renal prostaglandin system
28. Clinical effects of early ACE inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: Systematic analysis of individual data from nearly 96,000 randomized patients
29. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure
30. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: Results of a Veterans Administration Cooperative Study
31. Effects of indomethacin alone and during diuretic or β-adrenoreceptor blockade therapy on blood pressure and the renin system in essential hypertension
32. A prospective study of aspirin use and primary prevention of cardiovascular disease in women
33. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension
34. Aspirin-induced depression of glomerular filtration rate in normal humans: Role of sodium balance
35. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: Subgroup analysis of the Cooperative New Scandinavian Enalapril Survival study II (CONSENSUS II)
36. Pathophysiology of congestive heart failure
37. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man
38. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
39. Renal side effects of non-steroidal antiinflammatory drugs: Clinical relevance
40. Use of converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction
41. Studies of left ventricular dysfunction (SOLVD): Subgroup results
42. The influence of indomethacin on blood pressure during the infusion of vasopressors
43. Studies of the clinical pharmacology of prazosin
44. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction
45. The influence on some pharmacological action of atenolol
46. Acute hypotensive effect of captopril modified by prostaglandin synthesis inhibition
47. Attenuation of furosemide's diuretic effect by indomethacin: Pharmacokinetic evaluation
48. Captopril induced changes in prostaglandin production
49. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
50. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
51. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
52. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
53. Final Report on the aspirin component of the ongoing physicians' health study
54. Antagonism of spironolactone-induced natriuresis by aspirin in man
55. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
56. Attenuation of the hypotensive effect of propranolol and thiazide diuretics by indomethacin
57. Flurbiprofen interaction with single doses of atenolol and propranolol
58. Involvement of prostaglandins in actions of captopril
59. Prostaglandins, vasopressin, and renal water reabsorption